pharmaceutical lithium

From Aaushi
Jump to navigation Jump to search

Indications

* pharmaceutical lithium associated with decreased risk of dementia (RR=0.56) including Alzheimer's disease & vascular dementia[1]

Laboratory

More general terms

More specific terms

Additional terms

References

  1. 1.0 1.1 Chen S, Underwood BR, Jones PB et al Association between lithium use and the incidence of dementia and its subtypes: A retrospective cohort study. PLOS Medicine 2022. March 17. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28832877 PMCID: PMC5710473 Free PMC article https://doi.org/10.1371/journal.pmed.1003941